A A A
Day at the Registry: Naloxone company lobbies for wider use of nasal spray
Marijuana companies, excise tax advocacy and health top new registry filings in the last few weeks
News | SAMANTHA WRIGHT ALLEN
Published: Monday, 05/08/2017 5:32 pm EDT
Photo via Adapt Pharma Canada Ltd.
Adapt Pharma Canada Ltd. has registered to lobby the federal government to encourage wider use of its naloxone spray, which can reverse opioid overdoses.
To View the rest of this article, please choose one of the following
If you are already a subscriber
Subscribe to The Lobby Monitor
Sign Up for a free trial
For instant access to the website.